193 related articles for article (PubMed ID: 27942451)
21. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.
Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH
Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163
[TBL] [Abstract][Full Text] [Related]
22. The role of global and regional gray matter volume decrease in multiple sclerosis.
Grothe M; Lotze M; Langner S; Dressel A
J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
[TBL] [Abstract][Full Text] [Related]
23. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional abnormalities in Parkinson's disease based on voxel-based morphometry and resting-state functional magnetic resonance imaging.
Zheng JH; Sun WH; Ma JJ; Wang ZD; Chang QQ; Dong LR; Shi XX; Li MJ; Gu Q; Chen SY
Neurosci Lett; 2022 Sep; 788():136835. PubMed ID: 35963477
[TBL] [Abstract][Full Text] [Related]
25. Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy.
Alvim MK; Coan AC; Campos BM; Yasuda CL; Oliveira MC; Morita ME; Cendes F
Epilepsia; 2016 Apr; 57(4):621-9. PubMed ID: 26865066
[TBL] [Abstract][Full Text] [Related]
26. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
27. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
[TBL] [Abstract][Full Text] [Related]
28. Pontine and cerebral atrophy in Lennox-Gastaut syndrome.
Newham BJ; Curwood EK; Jackson GD; Archer JS
Epilepsy Res; 2016 Feb; 120():98-103. PubMed ID: 26808205
[TBL] [Abstract][Full Text] [Related]
29. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.
Steinbach R; Batyrbekova M; Gaur N; Voss A; Stubendorff B; Mayer TE; Gaser C; Witte OW; Prell T; Grosskreutz J
Neuroimage Clin; 2020; 25():102094. PubMed ID: 31896467
[TBL] [Abstract][Full Text] [Related]
30. Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.
Lindig T; Bender B; Hauser TK; Mang S; Schweikardt D; Klose U; Karle KN; Schüle R; Schöls L; Rattay TW
J Neurol; 2015 Aug; 262(8):1961-71. PubMed ID: 26050637
[TBL] [Abstract][Full Text] [Related]
31. Gray matter atrophy in presymptomatic Huntington's patients.
Király A; Kincses ZT; Szabó N; Tóth E; Csete G; Faragó P; Vécsei L
Ideggyogy Sz; 2016 Jul; 69(7-8):261-267. PubMed ID: 29465891
[TBL] [Abstract][Full Text] [Related]
32. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M
Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036
[TBL] [Abstract][Full Text] [Related]
33. Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Ciampi E; Pareto D; Sastre-Garriga J; Vidal-Jordana A; Tur C; Río J; Tintoré M; Auger C; Rovira A; Montalban X
Mult Scler; 2017 Apr; 23(4):556-566. PubMed ID: 27354019
[TBL] [Abstract][Full Text] [Related]
34. Influence of Mild White Matter Lesions on Voxel-based Morphometry.
Goto M; Hagiwara A; Fujita S; Hori M; Kamagata K; Aoki S; Abe O; Sakamoto H; Sakano Y; Kyogoku S; Daida H
Magn Reson Med Sci; 2021 Mar; 20(1):40-46. PubMed ID: 32074592
[TBL] [Abstract][Full Text] [Related]
35. Brain-volume changes in young and middle-aged smokers: a DARTEL-based voxel-based morphometry study.
Peng P; Wang Z; Jiang T; Chu S; Wang S; Xiao D
Clin Respir J; 2017 Sep; 11(5):621-631. PubMed ID: 26404024
[TBL] [Abstract][Full Text] [Related]
36. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
[TBL] [Abstract][Full Text] [Related]
37. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
38. Structural MRI correlates of amyotrophic lateral sclerosis progression.
Senda J; Atsuta N; Watanabe H; Bagarinao E; Imai K; Yokoi D; Riku Y; Masuda M; Nakamura R; Watanabe H; Ito M; Katsuno M; Naganawa S; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):901-907. PubMed ID: 28501822
[TBL] [Abstract][Full Text] [Related]
39. Structural correlates of apathy in Alzheimer's disease: a multimodal MRI study.
Agüera-Ortiz L; Hernandez-Tamames JA; Martinez-Martin P; Cruz-Orduña I; Pajares G; López-Alvarez J; Osorio RS; Sanz M; Olazarán J
Int J Geriatr Psychiatry; 2017 Aug; 32(8):922-930. PubMed ID: 27428560
[TBL] [Abstract][Full Text] [Related]
40. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.
Harper L; Bouwman F; Burton EJ; Barkhof F; Scheltens P; O'Brien JT; Fox NC; Ridgway GR; Schott JM
J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):908-916. PubMed ID: 28473626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
